The GLP-1 Podcast Show

In this episode of The GLP-1 Podcast Show, I speak with Dr. Ian Justl Ellis, a board-certified physician and founder of Voafit, about personalized GLP-1 treatment. Drawing on his experience as both a patient and physician, he explains how medication levels change as weekly doses accumulate, why individual responses can vary, and how gradual adjustments guided by appetite, side effects, nutrition, and objective progress support more personalized care. We also discuss patient monitoring, dose delivery challenges, and the clinical research needed to evaluate this approach at scale. Listen now on all major platforms. "The goal is a felt experience that is positive, that is resulting in objective changes." Meet the guest: Dr. Ian Justl Ellis https://www.linkedin.com/in/voafitmd is a board-certified physician and founder and CEO of Voafit. His work focuses on personalized GLP-1 care, precision dosing, and technology that supports individualized medication management. With a background in emergency medicine, fitness, and medical education, Dr. Ellis brings a multidisciplinary perspective to obesity care. Listen to Dr. Ian Justl Ellis on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: (00:00) Highlight (00:44) Introduction (01:49) Personal experience with obesity (07:40) Starting semaglutide (17:37) Precision dosing (24:53) A personalized dosing model (37:34) Dose delivery challenges (42:19) Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - WiseVAs (https://www.wisevas.io/) - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast

In this episode of The GLP-1 Podcast Show, I speak with Dr. Anders Fink-Jensen, Professor of Psychiatry at the University of Copenhagen and a consultant psychiatrist, about the emerging role of GLP-1 receptor agonists in addiction treatment. We examine the clinical observations that initiated this research, findings from a randomized trial of semaglutide for alcohol use disorder, possible effects on craving, dosing considerations, and the evidence still needed before broader clinical use. Listen now on all major platforms. "Semaglutide reduced both total alcohol consumption and the number of heavy drinking days." Meet the guest: Dr. Anders Fink-Jensen https://www.linkedin.com/in/anders-fink-jensen-b7a4a022 is a professor at the University of Copenhagen and a consultant psychiatrist. His research focuses on psychopharmacology, addiction, severe mental illness, and the clinical evaluation of GLP-1 receptor agonists in people with alcohol use disorder. Listen to Dr. Anders Fink-Jensen on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: (00:00) Highlight (00:58) Introduction (01:55) Origins of addiction research (06:16) Semaglutide trial design (10:58) Alcohol use outcomes (17:02) Patient selection (22:25) Future clinical research (25:58) Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast

In this episode of The GLP-1 Podcast Show, I speak with Dr. Michelle Gordon, a physician board-certified in obesity medicine and CEO of Thrive Span Medical, about obesity care for women in midlife. We discuss how GLP-1 therapy fits into long-term disease management, why slower weight reduction, adequate protein, resistance training, hydration, and fiber matter, and how hormonal changes may affect weight, cognition, and metabolic health. Dr. Gordon also explains when bariatric surgery remains appropriate and why obesity should be treated as a complex chronic disease. Listen now on all major platforms. "You need the amount of protein to also fuel your muscles, but it has to be coupled with resistance training." Meet the guest: Dr. Michelle Gordon https://www.linkedin.com/in/drmichellegordon is a physician board-certified in obesity medicine, lifestyle medicine, and general surgery. She is CEO of Thrive Span Medical, a physician-led telehealth clinic focused on midlife weight gain, menopause, and chronic disease. Her clinical work combines obesity medicine, hormone replacement when indicated, evidence-based lifestyle interventions, and personalized long-term care. Listen to Dr. Michelle Gordon on The GLP-1 Podcast Show, available on all major platforms. Want to stay up to date on the latest GLP-1 research and updates? Subscribe and never miss an episode: https://glp1podcast.com/ Liked this one? Don’t stop now. Here’s what we think you’ll love: https://www.wisenetix.co/blog?tag=the+glp-1+podcast+show What you will learn: (00:00) Highlight (01:34) Introduction (05:00) Gaps in women’s health research (10:12) Muscle preservation during weight loss (14:32) Estrogen and cognitive changes (18:31) Midlife metabolism (21:39) Long-term therapy (29:56) Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - Elevate (https://elevateagents.ai/) - WiseVAs (https://www.wisevas.io/) - ZentrixOS (https://zentrixos.com/) - Zentrix Insights (https://zentrixinsights.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast

In this episode of The GLP-1 Podcast Show, I speak with Dr. Jon Campbell, Associate Professor of Medicine at Duke University, about the changing science of GIP and glucagon. We examine GIP physiology, glucagon signaling, weight-independent metabolic effects, multi-receptor agonism, and variability in treatment response. Discover how emerging pharmacology could shape more precise obesity treatment. Listen now on all major platforms. "GI think it’s going to take a little while, but people are going to come around to this idea that glucagon, particularly when combined with an incretin like GIP or GLP-1, is a really powerful way to improve metabolic disease." Meet the guest: Dr. Jon Campbell is an Associate Professor of Medicine at Duke University. His research examines incretin hormones, pancreatic islet biology, and the cellular mechanisms that regulate glucose metabolism. His work has helped advance understanding of GIP, GLP-1, glucagon, and the signaling pathways that may shape future metabolic therapies. Listen to Dr. Jon Campbell on The GLP-1 Podcast Show, available on all major platforms. What you will learn: (00:00) Highlight (01:02) Introduction (02:09) GIP biology (06:04) Hormone contributions (11:45) Optimized agonists (15:33) Glucagon actions (19:21) Multi-hormone therapies (25:46) Closing thoughts The GLP-1 Podcast Show is trusted and supported by innovative companies like: - Zentrix Insights (https://zentrixinsights.com/) - ZentrixOS (https://zentrixos.com/) - WiseVAs (https://www.wisevas.io/) - Elevate (https://elevateagents.ai/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast

In this episode of The GLP-1 Podcast Show, I speak with Dr. Ashley Koff, registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot, about weight health in the GLP-1 era. She explains why body composition matters more than total weight, how digestion and hydration shape nutrition outcomes, why protein advice must be personalized, and how clinicians can support more sustainable metabolic health. Listen now on all major platforms. "Weight composition, including the type, amount, and location of bone, muscle, fat, and water, provides a more meaningful signal about health than total weight alone." Meet the guest: Dr. Ashley Koff https://www.linkedin.com/in/ashley-koff is a registered dietitian, founder of The Better Nutrition Program, and bestselling author of Your Best Shot: The Personalized System for Optimal Weight Health. She also serves as Nutrition Course Director for the Integrative and Functional Medicine Fellowship at the Susan Samueli Integrative Health Institute. Her work focuses on personalized nutrition, weight health optimization, metabolic health, practitioner education, and helping patients make better, sustainable choices. Listen to Dr. Ashley Koff on The GLP-1 Podcast Show, available on all major platforms. What you will learn: (00:00) Highlight (00:59) Introduction (03:58) Weight health (06:39) Success markers (08:59) Tracking trends (14:23) Functional status (20:49) Nutrition priorities (30:35) Future care The GLP-1 Podcast Show is trusted and supported by innovative companies like: - WiseVAs (https://www.wisevas.io/) - Elevate (https://elevateagents.ai/) - Zentrix Insights (https://zentrixinsights.com/) - ZentrixOS (https://zentrixos.com/) 𝗟𝗶𝘀𝘁𝗲𝗻 𝗼𝗻 𝗔𝗽𝗽𝗹𝗲 𝗣𝗼𝗱𝗰𝗮𝘀𝘁𝘀, 𝗦𝗽𝗼𝘁𝗶𝗳𝘆 𝗼𝗿 𝗮𝗻𝘆 𝗺𝗮𝗷𝗼𝗿 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. Website: https://theglp1podcast.com/ LinkedIn: https://www.linkedin.com/showcase/the-glp-1-podcast-show/ Instagram: https://www.instagram.com/theglp1podcast/ Facebook: https://www.facebook.com/profile.php?id=61577863745840 TikTok: https://www.tiktok.com/@theglp1podcast